Shekel Brainweigh Ltd (ASX: SBW) is a profitable company developing, manufacturing, marketing and distributing advanced weighing systems for the retail, healthcare and industrial markets for over 40 years.
It was an early participant in the development of digital scaling in the 1970s, and provides precision weighing solutions to customers including Toshiba, Fujitsu, Datalogic, Diebold-Nixdorf and GE Healthcare.
Shekel Brainweigh has established a network of global partners and clients in the retail and healthcare markets. The company designs and manufactures weighing systems for original equipment manufacturers (OEMs) including GE Healthcare, Toshiba, Fujitsu, Diebold-Nixdorf and Datalogic. These relationships provide Shekel Brainweigh with the data and testing ground to optimise its designs, as well as a broad distribution network for both existing and proposed new products. Geographically, Shekel Brainweigh’s products are sold across Australia, North and South America, China, Europe, Japan, New Zealand, Israel and Africa. Through this focus on the OEM market, Shekel Brainweigh has accelerated its revenue streams without the up-front costs of marketing and sales.
Recently, Shekel Brainweigh has developed its Product Aware Surface Technology. This Technology allows real-time identification of individual products and objects placed on a given surface (i.e. on a grocery shop shelf, etc.).
This exciting technology will allow retailers to know exactly what is on their shelf at any time and to track consumer behaviour, reducing the huge out of stock and overstock issues that supermarkets currently face. Given Shekel’s scale and weighing technology has been present in some of the world’s largest supermarkets for many years, this should give them a huge head start in introducing this new technology to the major players.
The business model for this “Smart Shelf” technology is based around a Software as a Service (SaaS) model.
Shekel Brainweigh Ltd is seeking to raise $10.15 million via its IPO and on listing, the expected market capitalisation of approximately $48.65 million
The proceeds from the offer will be used to fund:
The Company currently generates income primarily from sales of scaling solutions and weighing systems to OEMs in the retail and healthcare sector globally and to industrial customers in Israel. Income is also derived from the sale of branded weighing products to the healthcare industry globally.
The Company also generates income from the provision of after-sales service to customers in Israel and France.
The following table sets out the consolidated revenue, gross profit, operating profit and profit after tax of the Group for the financial years ended 31 December 2015, 2016 and 2017.
The Group currently designs and manufactures a wide range of high-precision weighing systems for retail, healthcare and industrial sectors. The range consists of small weighing systems that integrate into self-checkout and Point of Sale (POS) solutions as an OEM component. In addition, the Company’s precision weighing systems were one of the first in the world to be incorporated to warmers and incubators for premature babies and are now sold as an integrated component for such products.
The Company also produces its own range of physician’s scales, special needs scales (such as wheelchair and ramp scales) and domestic scales. The Company markets these products under the Healthweigh® brand.
In addition to its existing products, the Company is developing and intends to sell the following products, which together comprise the Retail Solutions Suite:
Shekel Brainweigh Ltd is led by a board who have a strong understanding of the technology, experience leading emerging technology companies from start-up to large scale profitable companies. Key personnel include:
You are encouraged to read the Prospectus carefully as it contains detailed information about the Company and the Offer. Like all investments, an investment in the Company carries risk. As set out in Section 9 of the prospectus, Shekel Brainweigh Ltd is subject to a range of risks, including but not limited to intellectual property, reliance on key personnel, customer preference, development and commercialisation risks.
Section 734(6) disclosure: The issuer of the securities is Shekel Braingweigh Ltd ARBN 625 669 445. The securities to be issued are ordinary shares. The disclosure document for the offer can be obtained by clicking on the link above. The offers of the securities are made in, or accompanied by, a copy of the disclosure document. Investors should consider the disclosure document in deciding whether to acquire the securities. Anyone who wants to acquire the securities will need to complete the application form that will be in or will accompany the disclosure document (which can be done via the electronic application form which will become available by clicking the bid button above).
OnMarket has a limited allocation. The offer may close early and the 'Pay By' dates may change. Bids over $10,000 may be scaled back more heavily. Duplicate bids under the same investment profile, investor name or residential address may be cancelled.
Tap 'More Info' to get access to free research, all company releases, and invest instantly for shares.
Fiji Kava Ltd (ASX: FIJ) is focussed on the research, development and sale of medicinal kava extracts as a consumer product. The Company currently sources, produces and markets high quality kava products and intends to export and sell in Australia, USA, New Zealand and Hong Kong. These products include shots, powders, and capsules designed to promote relaxation, enhance sleep and reduce stress. The Company has established a 111-acre farm processing and extraction facility in Fiji with the aim of establishing the foundation for large scale production and sourcing of kava products.
Hearts and Minds Investments Ltd (ASX: HM1) aims to provide investors with a concentrated portfolio of highest conviction stock ideas from Australia’s leading Fund Managers, while also supporting Australian medical research institutes. The portfolio will consist of ~25 local and international listed securities as selected by leading fund managers including Magellan, Caledonia, Paradice Investment Management, Cooper investors and Regal Funds Management. Cornerstone commitments of $225 million have been received from sophisticated famility investors and other groups associated with the offer.
OnMarket is proud to be acting as a Broker to the Offer.
Shekel Brainweigh Ltd (ASX: SBW) is a profitable company specialising in the development of complex, high precision weighing technology, employing a multidisciplinary team of experts in the fields of analogue and digital scaling technology, AI and big data analytics, alongside a sales team with a proven track record in the global retail and healthcare markets. Customers include Toshiba, Fujitsu, Datalogic, Diebold-Nixdorf and GE Healthcare.
Nanoveu Limited (ASX: NVU) is an Australian innovative technology company, whose primary business is the development, distribution and licensing of 3D technology applications for the global smartphone market. Nanoveu’s EyeFly3DTM product uses a combination of software (application) and hardware (screen protector) to offer real time, affordable and easy to use 3D rendering and 2D-to-3D instant conversion of videos and photos on smartphones and tablets – without the use of 3D glasses.
AXS Group Limited (ASX Code: AXS) is an integrated software solution provider to the finance, insurance and funds sector. With over 40 clients in Australia, North America, Europe and Asia they are focussed on helping clients with their digital transformation, reducing time and cutting costs. The Company’s cloud based ARMnet platform currently is used to manage over $100 billion of assets and transactions that are accessible via smart phones, tablets or email from anywhere at any time.
Norwest Minerals Limited (ASX:NWM) is a gold and base metals exploration company with projects located among world-class mineral discoveries in Western Australia and boasts exciting walk-up drill targets. The Company has received binding firm commitments totalling $4,000,000 and is led by CEO, Charles Schaus, who has extensive experience as a manager in the resource industry. Norwest’s strategy is to focus on delineating an economically viable resource capable of transforming the Company from an explorer into a mineral producer.